HOUSTON (August 03, 2010)

Today, Memorial Hermann, Texas Oncology and US Oncology announced they will enter into a joint business relationship that will expand the spectrum of cancer care available at Memorial Hermann Memorial City Medical Center and Memorial Hermann Sugar Land Hospital.

"This new venture enables Memorial Hermann and Texas Oncology to greatly expand our respective clinical and organizational strengths. Together, we will offer the very best in radiation therapy services to patients served by these two hospitals," said Dan Wolterman, Memorial Hermann Health System Chief Executive Officer.

"Through this key partnership, patients will now have access to expanded services and can expect the highest standard of cancer care with the latest cancer therapies and most advanced treatments," said Steve Paulson, MD, president and chairman of the board, Texas Oncology. "These services will provide greater availability to key resources that will help patients fight cancer."

At Memorial Hermann Memorial City Medical Center, the relationship with Texas Oncology and US Oncology will enable the hospital to add new services such as stereotactic radiosurgery (SRS) for brain tumors and stereotactic body radiation therapy (SBRT) for appropriate body tumor in addition to expanding its ability to provide patients access to national cancer clinical trials via US Oncology Research for the latest therapeutic modalities and investigative therapies. Currently, the physicians associated with the Cancer Center at Memorial Hermann Memorial City treat all types of cancers and specialize in breast, colorectal, gynecological, head and neck, kidney, lung, neurological, prostate and thyroid cancers. The Center offers state-of-the-art treatment options for patients, including robotic-assisted surgery, radiation oncology, clinical trials and more.

"Our goal is to provide patients with access to the most advanced cancer treatments and tools," said Vivek Kavadi, MD, radiation oncologist at Texas Oncology and medical director of radiation oncology at US Oncology. "Not only does this partnership expand our services, but it allows our patients to be treated close to home."

The joint business relationship also includes Texas Oncology-Sugar Land's radiation oncology services. Located at 1350 First Colony Boulevard near the intersection of Highway 6, the 16,000-square-foot center provides complete, integrated cancer care and incorporates the latest, most effective diagnostic and treatment technologies, including PET/CT imaging and intensity modulated radiation therapy (IMRT).

For more information about Memorial Hermann, visit www.memorialhermann.org or call 713.222.CARE (2273). To learn more about Texas Oncology, visit www.TexasOncology.com or 1.888.864.ICAN (4426). To learn more about US Oncology, visit www.USOncology.com or 281-863-1000.